Yersinia pestis infection future or investigational therapies
|
Yersinia pestis infection Microchapters |
|
Differentiating Yersinia Pestis Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Yersinia pestis infection future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Yersinia pestis infection future or investigational therapies |
|
FDA on Yersinia pestis infection future or investigational therapies |
|
CDC on Yersinia pestis infection future or investigational therapies |
|
Yersinia pestis infection future or investigational therapies in the news |
|
Blogs on Yersinia pestis infection future or investigational therapies |
|
Risk calculators and risk factors for Yersinia pestis infection future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Future and Investigational Therapies
Research studies are under way to improve the plague vaccine. The qualities searched in the new vaccine include:
- Protection from airborne infection
- Inhaled administration
A current potential vaccine is a recombinant type, expressing both V and F1 antigens of Yersinia pestis. This vaccine appears to protect animals against this type of infection as well. Other options include:
- Aerosolized monoclonal antibodies
- Attenuated form of Yersinia pseudotuberculosis